Cargando…

Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”

BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidenfaden, Sophie-Charlott, Kjerulff, Julie Linding, Juul, Niels, Kirkegaard, Hans, Møller, Mette Fogh, Münster, Anna-Marie Bloch, Bøtker, Morten Thingemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173808/
https://www.ncbi.nlm.nih.gov/pubmed/34078435
http://dx.doi.org/10.1186/s13049-021-00891-5
_version_ 1783702781726556160
author Seidenfaden, Sophie-Charlott
Kjerulff, Julie Linding
Juul, Niels
Kirkegaard, Hans
Møller, Mette Fogh
Münster, Anna-Marie Bloch
Bøtker, Morten Thingemann
author_facet Seidenfaden, Sophie-Charlott
Kjerulff, Julie Linding
Juul, Niels
Kirkegaard, Hans
Møller, Mette Fogh
Münster, Anna-Marie Bloch
Bøtker, Morten Thingemann
author_sort Seidenfaden, Sophie-Charlott
collection PubMed
description BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury. METHODS: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14–15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion. RESULTS: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 μg/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used. CONCLUSION: Early prehospital and in-hospital S100B levels < 0.10 μg/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02867137. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13049-021-00891-5.
format Online
Article
Text
id pubmed-8173808
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81738082021-06-03 Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” Seidenfaden, Sophie-Charlott Kjerulff, Julie Linding Juul, Niels Kirkegaard, Hans Møller, Mette Fogh Münster, Anna-Marie Bloch Bøtker, Morten Thingemann Scand J Trauma Resusc Emerg Med Original Research BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury. METHODS: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14–15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion. RESULTS: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 μg/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used. CONCLUSION: Early prehospital and in-hospital S100B levels < 0.10 μg/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02867137. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13049-021-00891-5. BioMed Central 2021-06-02 /pmc/articles/PMC8173808/ /pubmed/34078435 http://dx.doi.org/10.1186/s13049-021-00891-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Research
Seidenfaden, Sophie-Charlott
Kjerulff, Julie Linding
Juul, Niels
Kirkegaard, Hans
Møller, Mette Fogh
Münster, Anna-Marie Bloch
Bøtker, Morten Thingemann
Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title_full Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title_fullStr Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title_full_unstemmed Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title_short Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
title_sort diagnostic accuracy of prehospital serum s100b and gfap in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the pretbi i study”
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173808/
https://www.ncbi.nlm.nih.gov/pubmed/34078435
http://dx.doi.org/10.1186/s13049-021-00891-5
work_keys_str_mv AT seidenfadensophiecharlott diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT kjerulffjulielinding diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT juulniels diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT kirkegaardhans diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT møllermettefogh diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT munsterannamariebloch diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy
AT bøtkermortenthingemann diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy